Health Blawg
JANUARY 16, 2019
HIPAA, everyone’s favorite scapegoat for all (OK, most) of the ills of the modern healthcare-industrial complex, is perpetually called out as being in dire need of a rewrite. The HIPAA RFI came next. A digression: As the health wonks and policy nerds reading this are already aware, HIPAA is a horse of a different color.
Health Blawg
JANUARY 16, 2019
HIPAA, everyone’s favorite scapegoat for all (OK, most) of the ills of the modern healthcare-industrial complex, is perpetually called out as being in dire need of a rewrite. The HIPAA RFI came next. A digression: As the health wonks and policy nerds reading this are already aware, HIPAA is a horse of a different color.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Chilmark Research
JANUARY 17, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Collecting data such as patient allergies or side effects appears a simpler use case on paper.
Health Blawg
DECEMBER 26, 2017
It is worth noting that the SaMD efforts are based on the principles articulated by a group of medical device regulators from around the world (IMDRF) which chartered a working group to look at SaMD; the IMDRF document was unanimously approved by its management committee and was adopted by the FDA. The Harlow Group LLC.
Health Blawg
DECEMBER 26, 2017
It is worth noting that the SaMD efforts are based on the principles articulated by a group of medical device regulators from around the world (IMDRF) which chartered a working group to look at SaMD; the IMDRF document was unanimously approved by its management committee and was adopted by the FDA. The Harlow Group LLC.
Health Blawg
DECEMBER 26, 2017
It is worth noting that the SaMD efforts are based on the principles articulated by a group of medical device regulators from around the world (IMDRF) which chartered a working group to look at SaMD; the IMDRF document was unanimously approved by its management committee and was adopted by the FDA. The Harlow Group LLC.
Health Blawg
DECEMBER 26, 2017
It is worth noting that the SaMD efforts are based on the principles articulated by a group of medical device regulators from around the world (IMDRF) which chartered a working group to look at SaMD; the IMDRF document was unanimously approved by its management committee and was adopted by the FDA. The Harlow Group LLC.
Expert insights. Personalized for you.
60 
Let's personalize your content